Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DISPAIR vs. D-FRS - Establishing the Superiority of the Novel Distal Pancreatectomy Pancreatic Fistula Risk Prediction Models - A Multicenter International Retrospective Validation Study

NCT05737875 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT05737875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05737875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DISPAIR vs. D-FRS - Establishing the Superiority of the Novel Distal Pancreatectomy Pancreatic Fistula Risk Prediction Models - A Multicenter International Retrospective Validation Study
Lead sponsor
University of Edinburgh
Phase
Observational
Overall status
Completed
Start date
April 7, 2023
Completion date
April 6, 2025
Enrollment
2,284 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatectomy, pancreatic fistula